| The AMPK inhibitor compound C is a potent AMPK-independent antiglioma agent X Liu, RR Chhipa, I Nakano, B Dasgupta Molecular cancer therapeutics 13 (3), 596-605, 2014 | 301 | 2014 |
| Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK X Liu, RR Chhipa, S Pooya, M Wortman, S Yachyshin, LML Chow, ... Proceedings of the National Academy of Sciences 111 (4), E435-E444, 2014 | 257 | 2014 |
| The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signalling pathway MV Vijayakumar, S Singh, RR Chhipa, MK Bhat British journal of pharmacology 146 (1), 41-48, 2005 | 205 | 2005 |
| Serine/threonine kinase MLK4 determines mesenchymal identity in glioma stem cells in an NF-κB-dependent manner SH Kim, R Ezhilarasan, E Phillips, D Gallego-Perez, A Sparks, D Taylor, ... Cancer cell 29 (2), 201-213, 2016 | 158 | 2016 |
| FOXD1–ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells P Cheng, J Wang, I Waghmare, S Sartini, V Coviello, Z Zhang, SH Kim, ... Cancer research 76 (24), 7219-7230, 2016 | 144 | 2016 |
| Evolving lessons on the complex role of AMPK in normal physiology and cancer B Dasgupta, RR Chhipa Trends in pharmacological sciences 37 (3), 192-206, 2016 | 133 | 2016 |
| Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma H Sadahiro, KD Kang, JT Gibson, M Minata, H Yu, J Shi, R Chhipa, ... Cancer research 78 (11), 3002-3013, 2018 | 127 | 2018 |
| AMP kinase promotes glioblastoma bioenergetics and tumour growth RR Chhipa, Q Fan, J Anderson, R Muraleedharan, Y Huang, G Ciraolo, ... Nature cell biology 20 (7), 823-835, 2018 | 119 | 2018 |
| AMPK-mediated autophagy is a survival mechanism in androgen-dependent prostate cancer cells subjected to androgen deprivation and hypoxia RR Chhipa, Y Wu, C Ip Cellular signalling 23 (9), 1466-1472, 2011 | 98 | 2011 |
| Direct interaction with and activation of p53 by SMAR1 retards cell‐cycle progression at G2/M phase and delays tumor growth in mice R Kaul, S Mukherjee, F Ahmed, MK Bhat, R Chhipa, S Galande, ... International journal of cancer 103 (5), 606-615, 2003 | 91 | 2003 |
| Prx1 enhances androgen receptor function in prostate cancer cells by increasing receptor affinity to dihydrotestosterone RR Chhipa, KS Lee, S Onate, Y Wu, C Ip Molecular Cancer Research 7 (9), 1543-1552, 2009 | 65 | 2009 |
| Androgen receptor-mTOR crosstalk is regulated by testosterone availability: implication for prostate cancer cell survival YUE Wu, RR Chhipa, J Cheng, H Zhang, JL Mohler, C Ip Anticancer research 30 (10), 3895-3901, 2010 | 64 | 2010 |
| Survival advantage of AMPK activation to androgen-independent prostate cancer cells during energy stress RR Chhipa, Y Wu, JL Mohler, C Ip Cellular signalling 22 (10), 1554-1561, 2010 | 55 | 2010 |
| Methyl-β-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: Involvement of Akt, NF-κB and Bcl-2 AK Upadhyay, S Singh, RR Chhipa, MV Vijayakumar, AK Ajay, MK Bhat Toxicology and applied pharmacology 216 (2), 177-185, 2006 | 53 | 2006 |
| Doxycycline potentiates antitumor effect of cyclophosphamide in mice RR Chhipa, S Singh, SV Surve, MV Vijayakumar, MK Bhat Toxicology and applied pharmacology 202 (3), 268-277, 2005 | 46 | 2005 |
| Direct inhibition of retinoblastoma phosphorylation by nimbolide causes cell-cycle arrest and suppresses glioblastoma growth S Karkare, RR Chhipa, J Anderson, X Liu, H Henry, A Gasilina, N Nassar, ... Clinical Cancer Research 20 (1), 199-212, 2014 | 43 | 2014 |
| Bystander killing of breast cancer MCF‐7 cells by MDA‐MB‐231 cells exposed to 5‐fluorouracil is mediated via Fas RR Chhipa, MK Bhat Journal of cellular biochemistry 101 (1), 68-79, 2007 | 31 | 2007 |
| DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells S Singh, RR Chhipa, MV Vijayakumar, MK Bhat Cancer letters 236 (2), 213-221, 2006 | 30 | 2006 |
| The antiandrogenic effect of finasteride against a mutant androgen receptor Y Wu, RR Chhipa, H Zhang, C Ip Cancer biology & therapy 11 (10), 902-909, 2011 | 25 | 2011 |
| Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway R Kumari, S Chouhan, S Singh, RR Chhipa, AK Ajay, MK Bhat Journal of biosciences 42, 31-41, 2017 | 24 | 2017 |
